Suchergebnisse - "Xu, Binghe"

PubPharm (122)

21

Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer : Primary results from PALOMA-4

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Xu, B. | Hu, X. | Li, W. | +15

22

Accelerating the integration of China into the global development of innovative anticancer drugs

enthalten in: The Lancet. Oncology | 2022

von Huang, H. | Wu, D. | Miao, H. | +12

23

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer

enthalten in: JAMA network open | 2022

von Mo, H. | Yan, X. | Zhao, F. | +11

24

Breast cancer : an up-to-date review and future perspectives

enthalten in: Cancer communications (London, England) | 2022

von Hong, R. | Xu, B.

25

Whole-genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer

enthalten in: Clinical and translational medicine | 2022

von Gao, Y. | Zhao, H. | An, K. | +15

26

Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer : A prospective cohort study with propensity-matched analysis

enthalten in: International journal of cancer | 2022

von Xiu, M. | Zhang, P. | Wang, X. | +9

27

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients

enthalten in: Cancer medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10

28

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

enthalten in: The New England journal of medicine | 2022

von Cortés, J. | Kim, S. | Chung, W. | +122

CommentIn: Nat Rev Clin Oncol. 2022 May;19(5):283. - PMID 35361895

29

Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression

enthalten in: Cancer letters | 2021

von Li, C. | Qiu, S. | Jin, K. | +5

30

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

enthalten in: Cancer cell | 2021

von Zhang, Y. | Chen, H. | Mo, H. | +17

CommentIn: Cancer Cell. 2021 Dec 13;39(12):1562-1564. - PMID 34767761